Prescription drug · ANDA
Citalopram NDC 70518-2553
Citalopram hydrobromide 10 mg/1 · Tablet, Film coated · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-2553-1 | 70518255301 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2553-1)Marketed from Jan 30, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Citalopram
- Generic name (nonproprietary)
- citalopram
- Active ingredients
- Citalopram hydrobromide — 10 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077042
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 70518-2553_579809cc-2da1-0ba6-e063-6294a90a2099SPL ID 579809cc-2da1-0ba6-e063-6294a90a2099SPL set ID f79f878e-99fb-4757-8abb-931af1fa9e2bRxCUI 283672UNII I1E9D14F36
- Pharmacologic class
- Serotonin Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518255301followed by a unit qualifier and the quantityPackage 70518-2553-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] . Citalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ) .
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077042
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Citalopram | Citalopram hydrobromide 10 mg/1 | Tablet, Film coatedOral | Mylan Pharmaceuticals Inc. | 0378-6231 |
| Citalopram | Citalopram hydrobromide 20 mg/1 | Tablet, Film coatedOral | Mylan Pharmaceuticals Inc. | 0378-6232 |
| Citalopram | Citalopram hydrobromide 40 mg/1 | Tablet, Film coatedOral | Mylan Pharmaceuticals Inc. | 0378-6233 |
| Citalopram | Citalopram hydrobromide 40 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-2232 |
| Citalopram | Citalopram hydrobromide 40 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-2601 |
| Citalopram | Citalopram hydrobromide 40 mg/1 | Tablet, Film coatedOral | NuCare Pharmaceuticals,Inc. | 68071-3558 |